1. Acupuncture to Improve Symptoms for Stable Angina: Protocol for a Randomized Controlled Trial
- Author
-
Glorieuse Uwizeye, Joan Briller, Hui Yan Cai, Hiroyoshi Yajima, Nobuari Takakura, Judith M. Schlaeger, Adhir Shroff, Heather Pauls, Veronica Angulo, Holli A. DeVon, Debra Hoppensteadt, Miho Takayama, and Alana Steffen
- Subjects
medicine.medical_specialty ,stable angina ,Traditional Chinese medicine ,030204 cardiovascular system & hematology ,law.invention ,Angina ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Randomized controlled trial ,law ,Acupuncture ,medicine ,Protocol ,complementary medicine ,Medical prescription ,business.industry ,General Medicine ,medicine.disease ,ischemic heart disease ,3. Good health ,McGill Pain Questionnaire ,Physical therapy ,Health education ,business ,030217 neurology & neurosurgery ,acupuncture - Abstract
BackgroundAcupuncture has demonstrated physiologic analgesic effects in Chinese patients with stable angina. One proposed mechanism of action for these analgesic effects is the downregulation of M1 macrophages, interleukin 1 beta, interleukin-6, interleukin-18, and tumor necrosis factor alpha.ObjectiveThis study aims to test a 10-session, 5-week acupuncture treatment protocol as a complementary therapy for symptoms of stable angina for American patients, who vary from Chinese patients in health care systems and other salient variables.MethodsWe are conducting a randomized controlled trial (RCT) of 69 adults (35 assigned to initial acupuncture and 34 to an attention control condition) with a medically confirmed diagnosis of stable angina, whose pain and associated symptoms have not been controlled to their satisfaction with guideline-directed medical management. Participants in the experimental group will receive a standardized traditional Chinese medicine point prescription. The attention control group will view non–pain-related health education videos over 5 weeks equal to the 10 hours of treatment for the acupuncture group. Participants will complete the McGill Pain Questionnaire and the Seattle Angina Questionnaire-7, as well as have inflammatory cytokines measured at baseline and study completion. The primary outcomes are anginal pain and quality of life.ResultsThis study has been funded over 2 years by the National Institutes of Health, National Institute for Nursing Research. We are currently recruiting and expect to have initial results by December 2020.ConclusionsWe will generate data on feasibility, acceptability, effect sizes, and protocol revisions for a future fully powered RCT of the protocol. Findings will help determine if patients with persistent ischemic symptoms experience a proinflammatory state and hyperalgesia caused by multiple neural and immune processes not always relieved with medication.International Registered Report Identifier (IRRID)DERR1-10.2196/14705
- Published
- 2019